Risk factor
High price volatility
Profitability factor
Greatly overvalued vs peers
About
Selvas AI Inc. operates as an artificial intelligence (AI) company in South Korea. The company offers Selvy Note, an AI Voice Record for recognizing the content of conversations such as research, consultation, and meetings; Selvy MediVoice, an AI medical voice recognition that generates medical records during the medical process through voice; Selvy SpeechEdu, an AI training voice recognition for text utilization learning, sentence pronunciation accuracy learning, and sophisticated pronunciation at the phoneme/phonetic level. It also provides odiro, an AI voice content creation solution; Selvy Alrimi, an AI announcement solution to enter the broadcast content as text and the announcement voice can be automatically transmitted at the desired time; Selvy Checkup, an AI disease occurrence probability prediction solution; OnFit, an IoT-based smart fitness/fitness membership management program; Selpub, a cloud-based multimedia eBook; and DIODICT, a mobile electronic dictionary. The company was formerly known as DIOTEK Co., Ltd. and changed its name to Selvas AI Inc. in September 2016. Selvas AI Inc. was founded in 1999 and is based in Seoul, South Korea.
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBITDA,
Buy
Sell